Regeneron Drug Prevents Symptomatic Covid-19 in Study

The antibody drug reduced the risk of developing symptomatic Covid-19 infection by 81% compared with a placebo in people living with someone infected by the new coronavirus, a study found.

 
Ardian Banks $8.9 Billion for Buyouts

Ardian, one of Europe's biggest private-equity firms, has wrapped up fundraising for its largest-ever buyout vehicle and plans to invest the roughly EUR7.5 billion (about $8.9 billion) with a trans-Atlantic flair.

 
Alibaba, Hit by Antitrust Fine, Vows to Help Vendors With Fee Cuts

Alibaba said it would invest in measures to support merchants on its platform, two days after China's antitrust regulator imposed a record fine against the company for abusing its dominant position over vendors and rivals in the country's e-commerce industry.

 
Suez, Veolia Climb On Merger Deal In Principle

Suez and Veolia Environnement rose sharply after the companies said they'd reached a deal in principle on a merger, with Veolia to pay EUR20.50 a share.

 
DiaSorin To Buy U.S.-based Luminex

Shares of Italy's DiaSorin surged 7% after the diagnostic specialist announced a deal to buy Covid-19 testing kit maker Luminex for around $1.8 billion.

 
Vox Media to Buy Owner of Preet Bharara's Podcast

Vox Media is acquiring Cafe Studios, publisher of a podcast hosted by the former Manhattan U.S. attorney, part of a bid to expand its growing audio business.

 
Supply-Chain Software Provider Blue Yonder Weighs IPO

The company is the latest technology provider to look at a public stock offering as pandemic-driven upheaval in supply chains draws more interest to tools that help companies manage the flow of goods.

 
Google's Secret 'Project Bernanke' Revealed in Texas Antitrust Case

The program used past bid data to boost the tech company's win rate in advertising auctions, according to a court filing.

 
CEOs Plan New Push on Voting Legislation

Companies from PayPal to AMC have signaled they will support joining effort for voter access.

 
Medline Industries Explores Sale

Medline Industries is exploring a sale that could value the big medical-supply company at as much as $30 billion and mark the latest in a recent string of large leveraged-buyout bids.

(END) Dow Jones Newswires

April 12, 2021 05:15 ET (09:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.